Sign In
Buy NVO
$47.41
-0.0100 (-0.0211%)
At Close: Jun 24, 2026
NOVO URGENT DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
10:14am, Monday, 29'th Sep 2025
Novo allegedly overstated GLP-1 growth; stock plunged 21.8% on July 29, 2025 after lowering outlook due to compounded drugs, weak expansion, competition.
Novo Nordisk Stock Is Downgraded. There's a ‘Tough Path Ahead.
10:13am, Monday, 29'th Sep 2025
U.S. prescriptions for Novo's Ozempic and Wegovy drugs are stagnating, Morgan Stanley analysts said.
NVO Downgrade Sell-Off, Defense Rally, CCL Cruises on Earnings
10:01am, Monday, 29'th Sep 2025
Carnival (CCL) cruised on an earnings beat and optimism for strong demand ahead. Diane King Hall takes a closer look at the report to show other strengths boosting the cruise line's pocketbook.
Novo Nordisk: Leading bank downgrades drug marker, shares down 2%
09:11am, Monday, 29'th Sep 2025
Novo Nordisk (NYSE:NVO) has been knocked back by Morgan Stanley, which has cut its rating on the Danish drugmaker from equal weight to underweight and lowered its price target from DKr 380 to DKr 300.
Novo Nordisk A/S Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - NVO
08:45am, Monday, 29'th Sep 2025
NEW YORK , Sept. 29, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Novo Nordisk A/S (NYSE: NVO).
Morgan Stanley expects Novo Nordisk Alzheimer trial to fail as it slashes rating
05:36am, Monday, 29'th Sep 2025
Morgan Stanley analysts say a trial to test whether Novo Nordisk's blockbuster weight-loss drug also will work against Alzheimer's is likely to fail, as it set the most pessimistic target price foreca
NEW YORK , Sept. 28, 2025 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Novo Nordisk A/S ("Novo Nordisk" or the "Company") (NYSE: NVO).
3 Magnificent Stocks Under $100 to Buy Right Now
06:45am, Saturday, 27'th Sep 2025
Share price has nothing to do with whether a stock is fairly valued. However, it is nonetheless an important consideration for investors on tight budgets.
Novo Nordisk A/S (NVO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
03:27pm, Friday, 26'th Sep 2025
LOS ANGELES , Sept. 26, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Novo Nordisk A/
Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVO
03:15pm, Friday, 26'th Sep 2025
LOS ANGELES--(BUSINESS WIRE)--Novo Nordisk A/S Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – NVO.
A New Prescription For Pain: Understanding Trump's 100% Pharma Tariff
02:37pm, Friday, 26'th Sep 2025
Novo Nordisk, Sanofi, and AstraZeneca face the largest dollar exposure to President Trump's new 100% tariff on imported branded drugs. NVO's heavy reliance on U.S. sales and imported GLP-1 products pu
NEW YORK, Sept. 26, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
NOVO DEADLINE ALERT: Bragar Eagel & Squire, P.C. Urges Novo Nordisk Investors to Contact the Firm Before September 30th
10:57am, Friday, 26'th Sep 2025
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Novo (NVO) To Contact Him Directly To Discuss Their Options If you purchased or acquired s
NEW YORK , Sept. 26, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Novo Nordisk A/S ("Novo" or the "Company") (NYSE: NVO) of a class action securities lawsuit.
Novo Nordisk: Wegovy Sales Soar, Trump Tariffs No Threat
08:45am, Friday, 26'th Sep 2025
Despite the difficulties Novo Nordisk's GLP-1 franchise has encountered due to Eli Lilly and manufacturers of compounded versions of semaglutide, demand for Wegovy remains strong. So, its sales amount
